Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H13I3N2O3 |
| Molecular Weight | 661.9994 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C(I)C(C(=O)N(CCC(O)=O)C2=CC=CC=C2)=C(I)C=C1I
InChI
InChIKey=FJYJNLIEGUTPIJ-UHFFFAOYSA-N
InChI=1S/C16H13I3N2O3/c17-10-8-11(18)15(20)14(19)13(10)16(24)21(7-6-12(22)23)9-4-2-1-3-5-9/h1-5,8H,6-7,20H2,(H,22,23)
| Molecular Formula | C16H13I3N2O3 |
| Molecular Weight | 661.9994 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/14236022
Sources: http://www.ncbi.nlm.nih.gov/pubmed/14236022
Iobenzamic acid is a contrast medium, which was used for cholecystography under the name Osbil. It is assumed that the drug is no longer marketed.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
500 mg single, oral Recommended |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Nausea, Headache... Other AEs: Nausea (27%) Sources: Headache (18%) Vomiting (5%) Pain (6%) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Headache | 18% | 500 mg single, oral Recommended |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Nausea | 27% | 500 mg single, oral Recommended |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Vomiting | 5% | 500 mg single, oral Recommended |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Pain | 6% | 500 mg single, oral Recommended |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis. | 1979-11 |
|
| "OSBIL"--A CLINICAL TRIAL. | 1965-07 |
|
| [Experience with Osbil, a new oral biliary contrast medium]. | 1962-02-17 |
|
| [Experience with Osbil, a contrast medium for oral cholecystography]. | 1962-02-11 |
|
| [Osbil, a new oralbile contrast medium]. | 1962-01-12 |
|
| [Osbil, a new contrast medium for oral cholangiocholecystography]. | 1961-07-07 |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/14236022
Unknown
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:44:55 GMT 2025
by
admin
on
Mon Mar 31 18:44:55 GMT 2025
|
| Record UNII |
F72UWG2SWK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
V08AC05
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
||
|
WHO-VATC |
QV08AC05
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3759
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
DTXSID9057711
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
DB13428
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
F72UWG2SWK
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106317
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
100000083421
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
3115-05-7
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
C170072
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
m772
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
Iobenzamic acid
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
221-484-1
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
SUB08204MIG
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
1560
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY | |||
|
18377
Created by
admin on Mon Mar 31 18:44:55 GMT 2025 , Edited by admin on Mon Mar 31 18:44:55 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |